Lonny Stokholm
Overview
Explore the profile of Lonny Stokholm including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
110
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thinggaard B, Subhi Y, Grauslund J, Stokholm L
Acta Ophthalmol
. 2025 Feb;
PMID: 39901612
No abstract available.
2.
Grauslund J, Taha A, Molander L, Kawasaki R, Moller S, Hojlund K, et al.
Int J Retina Vitreous
. 2024 Dec;
10(1):97.
PMID: 39696569
Background: Nonarteritic anterior ischemic optic neuropathy (NAION) is an untreatable condition often causing severe and irreversible visual loss in the affected eye. As it has recently been implied that the...
3.
Thinggaard B, Hansen K, Dinesen F, Pedersen M, Morso L, Subhi Y, et al.
Ophthalmol Ther
. 2024 Nov;
13(12):3047-3048.
PMID: 39495383
No abstract available.
4.
Thinggaard B, Hansen K, Dinesen F, Pedersen M, Morso L, Subhi Y, et al.
Ophthalmol Ther
. 2024 Sep;
13(12):3035-3046.
PMID: 39285124
Introduction: Neovascular age-related macular degeneration (nAMD) is the leading cause of irreversible vision loss in developed countries. However, a significant gap persists in understanding this population, exacerbated by their advanced...
5.
Moller S, Lykkegaard J, Hansen R, Stokholm L, Kjaer N, Ahrenfeldt L
Arch Gerontol Geriatr
. 2024 Aug;
127:105584.
PMID: 39094402
Background: In aging populations, understanding predictors of cognitive decline is essential. We aimed to investigate the risk of cognitive decline and dementia by sensory impairments across sex, age, and European...
6.
Thinggaard B, Pedersen F, Kawasaki R, Wied J, Subhi Y, Grauslund J, et al.
Acta Ophthalmol
. 2024 Jun;
102(8):953-962.
PMID: 38829028
Purpose: To report the incidence of post-injection endophthalmitis (PIE) and the cumulative risk associated with repeated injections of intravitreal anti-vascular endothelial growth factor (anti-VEGF). Methods: We employed nationwide registries in...
7.
Stokholm L, Pedersen F, Andersen N, Andresen J, Bek T, Dinesen S, et al.
Acta Ophthalmol
. 2024 May;
102(7):805-812.
PMID: 38761021
Purpose: To evaluate the five-year incidence of diabetic retinopathy (DR) and associated risk markers in patients with type 1 diabetes in the national Danish DR-screening programme. Methods: Based on national...
8.
Pedersen F, Stokholm L, Andersen N, Andresen J, Bek T, Hajari J, et al.
Diabetes
. 2024 Mar;
73(6):977-982.
PMID: 38498373
Article Highlights:
9.
Mabala D, Stokholm L, Andersen N, Andresen J, Bek T, Heegaard S, et al.
Acta Ophthalmol
. 2024 Feb;
102(6):635-642.
PMID: 38345204
Purpose: To investigate diabetic retinopathy (DR) as a potential marker of cardiovascular disease (CVD) in adults with type 1 diabetes attending the Danish DR-screening programme and non-diabetes adults. Methods: In...
10.
Thinggaard B, Frederiksen K, Subhi Y, Moller S, Sorensen T, Kawasaki R, et al.
Ophthalmol Sci
. 2024 Feb;
4(3):100446.
PMID: 38313400
Purpose: Controversy exists regarding the systemic safety of intravitreal VEGF inhibitors in the treatment of neovascular age-related macular degeneration (nAMD). We aimed to investigate the potential impact of VEGF inhibitor...